Varian Medical Systems (VAR +0.6%) gets a boost from an upgrade to Neutral at Goldman Sachs this morning. Goldman says its sell thesis on the stock has largely played out, and business fundamentals are stabilizing and consensus estimates now look reasonable. The firm also raises its price target from $62 to $79.